Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alina Krollenbrock"'
Publikováno v:
International Journal for Parasitology: Drugs and Drug Resistance, Vol 25, Iss , Pp 100546- (2024)
Schistosomiasis caused by Schistosoma spp. is a disease that causes a considerable health burden to millions of people worldwide. The limited availability of effective drugs on the market and the increased risk of resistance development due to extens
Externí odkaz:
https://doaj.org/article/a7b4e65d3ad143aeb62cd43bfaa39eea
Autor:
Martin J. Smilkstein, Sovitj Pou, Alina Krollenbrock, Lisa A. Bleyle, Rozalia A. Dodean, Lisa Frueh, David J. Hinrichs, Yuexin Li, Thomas Martinson, Myrna Y. Munar, Rolf W. Winter, Igor Bruzual, Samantha Whiteside, Aaron Nilsen, Dennis R. Koop, Jane X. Kelly, Stefan H. I. Kappe, Brandon K. Wilder, Michael K. Riscoe
Publikováno v:
Malaria Journal, Vol 18, Iss 1, Pp 1-17 (2019)
Abstract Background The potential benefits of long-acting injectable chemoprotection (LAI-C) against malaria have been recently recognized, prompting a call for suitable candidate drugs to help meet this need. On the basis of its known pharmacodynami
Externí odkaz:
https://doaj.org/article/630a94e7fc5a4c469f0ed0eacdad2650
Publikováno v:
ACS Infectious Diseases. 7:1956-1968
Robenidine is a veterinary drug used in the poultry industry to treat coccidiosis caused by parasites in the Eimeria genus. Though this compound and related aminoguanidines have recently been studied in other pathogens, the chemotype has not been sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cd1d19db69cb7ef67ce7903da2def01
https://doi.org/10.1021/acsinfecdis.1c00001
https://doi.org/10.1021/acsinfecdis.1c00001
Autor:
J. Stone Doggett, Sovitj Pou, Michael K. Riscoe, Igor Bruzual, Alina Krollenbrock, Aaron Nilsen, Rolf W. Winter, Erin V. McConnell, Martin J. Smilkstein, Rozalia Dodean, Lev N. Zakharov
Publikováno v:
ACS Infectious Diseases. 4:1574-1584
Cytochrome bc1 inhibitors have been broadly studied as human and veterinary medicines and agricultural fungicides. For the most part, cytochrome bc1 inhibitors compete with ubiquinol at the ubiquinol oxidation (Qo) site or with ubiquinone at the quin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caee187972389022baf5702049a19620
https://doi.org/10.1021/acsinfecdis.8b00133
https://doi.org/10.1021/acsinfecdis.8b00133
Autor:
Aaron Nilsen, Thomas Martinson, Alina Krollenbrock, Lisa Frueh, Lisa Bleyle, Rozalia Dodean, Samantha Whiteside, Igor Bruzual, David J. Hinrichs, Dennis R. Koop, Stefan H. I. Kappe, Sovitj Pou, Michael K. Riscoe, Jane Xu Kelly, Martin J. Smilkstein, Myrna Y. Munar, Rolf W. Winter, Yuexin Li, Brandon K. Wilder
Publikováno v:
Malaria Journal
Malaria Journal, Vol 18, Iss 1, Pp 1-17 (2019)
Malaria Journal, Vol 18, Iss 1, Pp 1-17 (2019)
BackgroundThe potential benefits of long-acting injectable chemoprotection (LAI-C) against malaria have been recently recognized, prompting a call for suitable candidate drugs to help meet this need. On the basis of its known pharmacodynamic and phar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89e9df3dea5dabbdc535615107019ec2
